TY - JOUR
T1 - Implementation of Best Practices—Developing and Optimizing Regional Systems of Stroke Care
T2 - Design and Methodology
AU - Ehrlich, Matthew E.
AU - Kolls, Brad J.
AU - Roettig, Mayme
AU - Monk, Lisa
AU - Shah, Shreyansh
AU - Xian, Ying
AU - Jollis, James G.
AU - Granger, Christopher B.
AU - Graffagnino, Carmelo
N1 - Funding Information:
L Monk: discloses salary support from IMPROVE grant funding by The Medtronic Foundation, Daiichi Sankyo and Chiesi.
Funding Information:
The IMPROVE Project Southeastern Consortium and all the dedicated 911, EMS, First Responders, and Hospital staff who are devoted to improving stroke care. Special gratitude to participating partner health systems and hub hospitals:, Atrium Carolinas Healthcare System Main. Atrium Carolinas Healthcare System Northeast. Novant Health Forsyth Medical Center. Novant Health Presbyterian Medical Center. Prisma Health Palmetto Health. Duke University Medical Center. HCA Healthcare Mission Hospital. Wake Forest Baptist Medical Center. New Hanover Regional Medical Center. The Medtronic Foundation: philanthropic grant. Daiichi Sankyo: non-CME educational grant. Chiesi: educational grant. ME Ehrlich: discloses salary support from IMPROVE grant funding by The Medtronic Foundation, and Daiichi Sankyo. BJ Kolls: discloses salary support from IMPROVE grant funding by The Medtronic Foundation. M Roettig: No disclosures. L Monk: discloses salary support from IMPROVE grant funding by The Medtronic Foundation, Daiichi Sankyo and Chiesi. S Shah: discloses salary support from IMPROVE grant funding by The Medtronic Foundation, and Daiichi Sankyo. Y Xian: discloses research grants from the American Heart Association, Daiichi Sankyo, Jansen Pharmaceuticals and Genentech, and honorarium from Boehringer Ingelheim and Portola. JG Jollis: discloses consultancy for Genentech. CB Granger: discloses salary support from AKROS, Apple, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Duke Clinical Research Institute, Glaxo Smith Kline, Medtronic Foundation, Pfizer; research support from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Duke Clinical Research Institute, Food and Drug Administration, Glaxo Smith Kline, Janssen Pharamceutica, Medtronic Foundation, Novartis, Pfizer; Consulting for Abbvie, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CeleCor Therapeutics, Espero BioPharma, Janssen Pharmaceutica, Medscape LLC, Medtronic Inc. Merck, NIH, Novo Nordisk, Novartis, Pfizer, and Roche Diagnostics. C Graffagnino: discloses salary support from IMPROVE grant funding by Medtronic Foundation; medical consultancy and clinical trial support from Daichi Sankyo; medical consultancy for Portola and research funding from Chiesi.
Funding Information:
Y Xian: discloses research grants from the American Heart Association, Daiichi Sankyo, Jansen Pharmaceuticals and Genentech, and honorarium from Boehringer Ingelheim and Portola.
Funding Information:
CB Granger: discloses salary support from AKROS, Apple, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Duke Clinical Research Institute, Glaxo Smith Kline, Medtronic Foundation, Pfizer; research support from AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Daiichi Sankyo, Duke Clinical Research Institute, Food and Drug Administration, Glaxo Smith Kline, Janssen Pharamceutica, Medtronic Foundation, Novartis, Pfizer; Consulting for Abbvie, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CeleCor Therapeutics, Espero BioPharma, Janssen Pharmaceutica, Medscape LLC, Medtronic Inc., Merck, NIH, Novo Nordisk, Novartis, Pfizer, and Roche Diagnostics.
Funding Information:
S Shah: discloses salary support from IMPROVE grant funding by The Medtronic Foundation, and Daiichi Sankyo.
Funding Information:
C Graffagnino: discloses salary support from IMPROVE grant funding by Medtronic Foundation; medical consultancy and clinical trial support from Daichi Sankyo; medical consultancy for Portola and research funding from Chiesi.
Publisher Copyright:
© 2020 Elsevier Inc.
PY - 2020/4
Y1 - 2020/4
N2 - The AHA Guidelines recommend developing multi-tiered systems for the care of patients with acute stroke.1 An ideal stroke system of care should ensure that all patients receive the most efficient and timely care, regardless of how they first enter or access the medical care system. Coordination among the components of a stroke system is the most challenging but most essential aspect of any system of care. The Implementation of Best Practices For Acute Stroke Care—Developing and Optimizing Regional Systems of Stroke Care (IMPROVE Stroke Care) project, is designed to implement existing guidelines and systematically improve the acute stroke system of care in the Southeastern United States. Project participation includes 9 hub hospitals, approximately 80 spoke hospitals, numerous pre-hospital agencies (911, fire, and emergency medical services) and communities within the region. The goal of the IMPROVE Stroke program is to develop a regional integrated stroke care system that identifies, classifies, and treats acute ischemic stroke patients more rapidly and effectively with reperfusion therapy. The project will identify gaps and barriers to implementation of stroke systems of care, leverage existing resources within the regions, aid in designing strategies to improve care processes, bring regional representatives together to agree on and implement best practices, protocols, and plans based on guidelines, and establish methods to monitor quality of care. The impact of implementation of stroke systems of care on mortality and long-term functional outcomes will be measured.
AB - The AHA Guidelines recommend developing multi-tiered systems for the care of patients with acute stroke.1 An ideal stroke system of care should ensure that all patients receive the most efficient and timely care, regardless of how they first enter or access the medical care system. Coordination among the components of a stroke system is the most challenging but most essential aspect of any system of care. The Implementation of Best Practices For Acute Stroke Care—Developing and Optimizing Regional Systems of Stroke Care (IMPROVE Stroke Care) project, is designed to implement existing guidelines and systematically improve the acute stroke system of care in the Southeastern United States. Project participation includes 9 hub hospitals, approximately 80 spoke hospitals, numerous pre-hospital agencies (911, fire, and emergency medical services) and communities within the region. The goal of the IMPROVE Stroke program is to develop a regional integrated stroke care system that identifies, classifies, and treats acute ischemic stroke patients more rapidly and effectively with reperfusion therapy. The project will identify gaps and barriers to implementation of stroke systems of care, leverage existing resources within the regions, aid in designing strategies to improve care processes, bring regional representatives together to agree on and implement best practices, protocols, and plans based on guidelines, and establish methods to monitor quality of care. The impact of implementation of stroke systems of care on mortality and long-term functional outcomes will be measured.
UR - http://www.scopus.com/inward/record.url?scp=85078734872&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85078734872&partnerID=8YFLogxK
U2 - 10.1016/j.ahj.2020.01.004
DO - 10.1016/j.ahj.2020.01.004
M3 - Article
C2 - 32028136
AN - SCOPUS:85078734872
SN - 0002-8703
VL - 222
SP - 105
EP - 111
JO - American heart journal
JF - American heart journal
ER -